Objective: To determine whether pulmonary hypertension developed in a coronary artery-ligated rabbit model of left ventricular Ž . Ž . Ž . dysfunction LVD and to examine the effects of i.v. 5-hydroxytryptamine 5-HT and endothelin-1 ET-1 on pulmonary arterial pressure Ž . PAP . Methods: Eight weeks after experimental coronary artery ligation or sham operation, ejection fractions were assessed by echocardiography. The rabbits were later anaesthetised and pulmonary arterial pressure was measured via a catheter inserted into the Ž . Ž . pulmonary artery via the right external jugular vein. 5-HT 1-400 mgrkg and ET-1 0.001-4 nmolrkg were administered i.v. Results: Ž Ejection fraction was significantly decreased from 76.6 " 1.4% in sham-operated to 42.2 " 1.3% in coronary artery-ligated rabbits n s 9 . in each group; P -0.001 , consistent with LVD. Baseline mean pulmonary arterial pressure was significantly increased in the coronary Ž . artery-ligated group compared to the shams, 16.5 " 0.5 vs. 11.5 " 0.8 mmHg; P -0.001 . A significant degree of right ventricular Ž Ž . hypertrophy was found in the coronary artery-ligated rabbits 0.70 " 0.04 grkg final body weight f.b.wt. , n s 8 cf. 0.48 " 0.02 grkg . f.b.wt. in sham-operated controls, n s 8; P -0.001 . There was a significant increase in the percentage of muscularised pulmonary Ž vessels adjacent to alveolar ducts and alveoli -60 mm i.d. in the LVD rabbits compared with their sham-operated controls 8.5 " 0.4 cf.
Introduction
Ž . Pulmonary hypertension PHT can occur as a primary or secondary phenomenon and is a consequence of many cardiopulmonary diseases where it often remains unidenti-) Ž .
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fied and therefore untreated. Once irreversible changes in pulmonary vasculature have occurred, pulmonary hypertension is associated with a poor prognosis, high mortality w x and is a contraindication to cardiac transplantation 1,2 .
The possibility that heart failure may be the commonest cause of PHT is often overlooked. Heart failure following Time for primary review 26 days.
0008-6363r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved. . various forms of left ventricular dysfunction LVD affects 1-2% of the entire population and associated PHT is w x common 3,4 .
The pulmonary circulation is normally a high-flow, low-pressure circuit, but persistent increases in left atrial pressure cause an elevation in pulmonary arterial pressure Ž . Ž . PAP and pulmonary vascular resistance PVR . However, the possibility of therapeutic intervention is limited as many standard vasodilators have a greater effect on the systemic circulation, causing hypotension, than on the w x pulmonary vasculature 5, 6 . In advanced PHT of any aetiology the pulmonary vascular endothelium undergoes both structural and functional changes which could have influences on substances produced by and drugs acting on w x the pulmonary circulation 7,8 . Right ventricular hypertrophy is an early and common consequence of PHT and an w x accurate marker of the development of PHT 9,10 . Ž . Ž . 5-hydroxytryptamine 5-HT and endothelin-1 ET-1 have been implicated in the aetiology of PHT. 5-HT is a pulmonary vasoconstrictor released from pulmonary neuroendocrine cells and platelets and has been associated with the progression of monocrotaline induced PHT in rats w x 11 . It has been demonstrated that isolated pulmonary arterial responses to 5-HT are potentiated in patients with primary PHT and in the chronic hypoxic rat model of PHT w x 12,13 . 5-HT has also been implicated in secondary PHT related to hypoxia in newborns and following cardiac w x surgery 14 .
ET-1 is a potent vasoconstrictor which has been implicated as a possible pathological mediator in diseases of w x most physiological systems 15 . Increased plasma levels of ET-1 have been observed in patients with secondary PHT due to chronic congestive heart failure and these increased levels were found to correlate with the extent of w x PHT and prognosis 16 . Increased levels of ET-1 production have also been shown in cases of PHT associated with w x congenital heart defects and mitral valve disease 17,18 . Endothelin antagonists have been shown to reduce the PHT associated with coronary artery ligation in the rat w x 19 .
There is substantial evidence to suggest a possible role for either of these vasoconstrictors in the development and progression of PHT secondary to heart failure. However, their precise role remains unknown.
This study was undertaken to compare the effects of left Ž . ventricular dysfunction LVD on pulmonary and systemic pressures and to determine the effect of artificially increasing circulating 5-HT and ET-1 on pulmonary arterial pressure.
Methods

Ž
Adult male New Zealand White rabbits n s 18, weigh-. ing 2.5-3.5 kg were used in this study.
Coronary ligation model
A well-characterised model of chronic left ventricular dysfunction secondary to coronary ligation was utilised w x 20 . Rabbits received premedication using intramuscular Ž . fentanylrfluanizone, 0.3-0.4 mlrkg Hypnorm, Jansen .
Ž . Anaesthesia was induced with midazolam 0.2-0.4 mlrkg and, following intubation was maintained with a mixture Ž . of nitrous oxide, oxygen 1:1 ratio and 1% halothane.
A left thoracotomy was performed through the 4th intercostal space to expose the heart. Quinidine hydrochlo-Ž . ride 3-5 mgrkg i.v. was administered prior to coronary artery ligation to reduce the incidence of ventricular fibrillation. The major branch of the left coronary artery was occluded approximately midway between the left atrial appendage and the cardiac apex. This gives rise to a large homogeneous infarct due to the poor collateral circulation of the rabbit coronary system. In cases where ventricular Ž fibrillation occurred usually 8-12 min following occlu-. sion , defibrillation was undertaken with an 8-J epicardial Ž shock. When an acceptable area of infarction approxi-. mately 20% of the left ventricle had been produced and the animal was haemodynamically and electrically stable, the thoracotomy was closed. In sham-operated controls, hearts were manipulated as in the coronary artery-ligated animals, but the artery was left unoccluded. 
Echocardiography
Echocardiographic examination of the animals was performed 8 weeks after coronary artery ligation or sham w x operation as previously described in detail 20 . This was Ž . performed under light sedation Hypnorm 0.3 mlrkg using a Toshiba SSH160A echocardiograph and a 5-MHz short focused paediatric transducer. A right parasternal transducer position was used which gives the best acoustic window and provides views of the left ventricle equivalent to the left parasternal window in man. M mode long axis measurements of left ventricular end diastolic dimension at the level just below the mitral valve and left atrial internal diastolic diameter at the level of the aortic root were made. By rotating the transducer 908, a short axis image enabled end-diastolic and end-systolic frames to be captured and traced onto the screen via an on-line cineloop computer analysis facility. This positioning was such that in the coronary artery-ligated animals, the short axis view rarely included an area of infarct and therefore, if anything, is likely to underestimate the severity of left ventricular dysfunction observed in these animals. The ejection frac-Ž . Ž tion EF was calculated as the end diastolic area y end . systolic area rend diastolic area.
All the measurements were made by a single operator. A repeat measures study was also performed to determine the reproducibility of image acquisition and analysis. Twelve animals were examined twice within 24-72 h. The coefficient of variation and the largest difference between consecutive measurements on the same animal were 2.3% and 1.3 mm for the dimension measurements and 3.9 and 5% for ejection fraction.
Measurement of pulmonary arterial pressure
Animals were anaesthetised as previously described and ventilated via a tracheal cannula. A specially designed Ž . J-shaped catheter Portex, 1.65 mm o.d. was manoeuvred into the right ventricle via the right external jugular vein and right atrium with the aid of X-ray image intensification and a guide wire. The guide wire was removed and the catheter positioned at the right ventricular outflow tract Ž using radio opaque dye. A smaller cannula Portex, 0.75 . mm o.d. was then passed through the wide bore cannula into the pulmonary artery. The catheter position was confirmed by the morphology of the pressure trace and by injection of radio opaque dye. The ascending aorta was cannulated via the right carotid artery. Following catheter placement, steady state with respect to systemic and pulmonary pressure was obtained before recordings were Ž . made. Baseline PAP and systemic arterial pressure SAP were measured using an Elcomatic E751A pressure transducer and recorded on a Siemens Elena Mingograph 803. 
Post mortem
At the end of each experiment, the animal was sacrificed and the location of the pulmonary artery catheter confirmed. The heart, lungs and liver were removed and weighed. Care was taken to dissect the right and left ventricles free of the septum as the ratio of right ventricle weightrfinal body weight was used as a measure of right Ž . ventricular hypertrophy RVH . This has been shown to be a reliable index of the degree of PHT present in experiw x mental animals 9,10 . A second group of sham and ligated animals were used for histological examination to determine the percentage of pulmonary vessels with thickened walls. Generally, pulmonary vessel muscularisation in models of PHT involves a peripheral extension of the muscular coat to vessels with a diameter of -60 mm i.d. Details of these methods and the validation of the vessel w x counting method have been described previously 21 and this is now considered to be an accurate method for the assessment of pulmonary vascular remodelling in PHT. The word ' vessel' is used rather than arteriole as small venules cannot readily be distinguished from arterioles in this method. Lungs from both groups of animals were paraffin embedded in a vacuum and 4-mm thick sections cut and stained with haemotoxylinreosin stains. For each lung, 100 small pulmonary vessels -60 mm i.d. next to alveoli and alveolar ducts were counted and examined for muscularisation from 20 fields at =40 magnification. A vessel was considered muscularised if the medial layer had at least three layers of smooth muscle i.e. was 15-25 mm thick. Normally, these vessels have virtually no detectable smooth muscle in the medial layer. The percentage of muscularised vessels was used as a measure of vascular remodelling.
Statistical methods
Student's two-sampled unpaired t-tests were applied for comparisons between the ligated and sham-operated groups. For continuous comparison between grouped data, Ž . correlation coefficients r were estimated for the degree of association between variables. If they were found to be significant, a scatter plot of the two sets of data were made and simple regression analysis was performed. A value of P -0.05 was taken as statistically significant. Table 1 shows that ejection fraction was significantly Ž lower in the coronary artery ligation group 42.2 " 1.3%, . n s 9; compared to 76.6 " 1.4% in the shams, n s 9 and there is no overlap in the ranges. In addition, both left atrial and left ventricular end diastolic diameters were significantly increased in the heart failure group. These w x values are similar to those reported previously 20 and show that in the coronary artery ligation group, there is evidence of left ventricular dysfunction.
Results
Echocardiographic data
Baseline haemodynamic characteristics of experimental groups
The baseline haemodynamic characteristics of the sham-operated controls and coronary artery-ligated ani- Table 2 . These measurements were taken immediately following the stabilisation period and prior to any drug administration. The baseline values for mean aortic pressure and heart rate were not different between the groups. There was an increase in systolic, mean and diastolic pulmonary arterial pressure in the Ž . Ž . coronary artery-ligated rabbits of 5.6 35% , 4 43% and Ž . 4.8 mmHg 51% respectively.
A significant correlation was found between ejection fraction and mean PAP for the population of animals used in this study, showing that poorer left ventricular function was associated with higher pulmonary arterial pressure Ž . Fig. 1 . Table 3 shows that there was a 46% increase in RV weights in the coronary artery-ligated group of animals indicative of a significant degree of RVH. It was found that development of this RVH correlated with a reduced Ž . ejection fraction Fig. 2 . There is also a trend towards heavier left ventricles despite approximately 20% of the left ventricle being infarcted and consisting of thin fibrous scar tissue, and lungs in the coronary artery-ligated rabbits Ž . Table 3 . The significant increase in PAP, together with the development of significant RVH, suggests that the coronary artery-ligated rabbits were developing PHT secondary to LVD. Fig. 3 . Graphs showing the effect of exogenous 5-HT on A mean pulmonary arterial pressure and B mean aortic pressure. Closed squares, coronary artery-ligated rabbits, ns6; open squares, sham-operated rabbits, ns 7. Data are shown as mean"s.e.m. ) P -0.05, ) ) P -0.01, and a P -0.001, for changes in pressure compared to baseline value, Student's paired t-test.
Effect of 5-HT and ET-1
During these experiments there were no alterations in the rate and depth of respiration during the course of any of the experiments. Any changes in respiration could have affected right atrial and therefore right ventricular filling pressure leading to indirect changes in the contractile state of the right ventricle so we can therefore be confident that any changes in arterial pressure represent effects on the circulation of the drugs administered.
5-Hydroxytryptamine
5-HT induced an increase in PAP in both the sham-operated controls and the coronary artery-ligated rabbits at concentrations as low as 1 mgrkg which reached a maxi-Ž . mum at a concentration of 200 mgrkg Fig. 3A . The changes in pressure were rapid, and occurred within 30 s of the administration of 5-HT. The increase in mean PAP observed at concentrations above 200 mgrkg was significantly greater in the coronary artery-ligated rabbits com-Ž . pared to the controls P -0.05 in each case . In contrast, 5-HT caused a gradual decrease in aortic pressure in both groups of animals which reached statistical significance at a concentration of 50 and 100 mgrkg in the sham and Ž . coronary ligation groups, respectively Fig. 3B . 
Endothelin 1
No significant effects of ET-1 on pulmonary arterial pressure were seen in either sham-operated or ligated Ž . animals Fig. 4A . In contrast, ET-1 resulted in significant Ž .
Ž . Fig. 4 . increases in aortic pressure at concentrations of 1-4 nmolrkg which were not different between the groups Ž . Fig. 4B . The systemic pressor response at each concentration generally reached a new steady state after ; 2 min and was extremely long lasting in that we did not see any recovery in pressure after the final dose of ET-1 within the 20-30 min we continued to observe pressures in some of the preliminary experiments. In 5 experiments, following the completion of the dose-response curve for ET-1, either Ž . a bolus of 5-HT 400 mgrkg; n s 3 or a further maximal Ž . dose of ET-1 4 nmolrkg; n s 2 was given and pulmonary arterial pressures monitored for 30 min. 5-HT always resulted in a pulmonary arterial pressor response confirming the viability of the pulmonary circulation. No effects of ET-1 were ever seen, even at this high final concentration, suggesting that we had not inadvertently missed a response with a much longer time course than that seen for the systemic circulation.
Histology
Lungs from 6 sham-operated and 7 ligated animals were examined. In the coronary artery-ligated animals, 20.9 " Ž . 0.4% range 19-22% of the vessels were considered to be muscularised, which was significantly greater than the Ž . Ž 8.5 " 0.4% range 7-10 seen in the control animals P -. 0.0005 . A significant correlation between the number of muscularised vessels and the ejection fraction was found indicating that LVD is associated with pulmonary vascular Ž . remodelling Fig. 5 . 
Discussion
As in previous studies, coronary artery ligation in these rabbits produced LVD, confirmed by significant left venw x tricular dilatation and a depressed ejection fraction 20,22 .
In this study, there was also a trend towards heavier left ventricles in coronary artery-ligated rabbits. This is indicative of hypertrophy in the surviving left ventricle as this reflects the weight of only ; 80% of the original left ventricle, the other 20% being infarcted and generally consisting of thin fibrous scar tissue.
The results presented here demonstrate that LVD was associated with the onset of PHT as indicated by right ventricular hypertrophy accompanied by elevated pulmonary arterial pressures and increased small pulmonary vessel muscularisation. There was also a trend towards lung congestion. It was not possible to measure PVR directly as the measurement of pulmonary wedge pressure or left atrial pressure was not possible. This difficulty is well recognised by workers using in vivo preparations and many studies use increased right ventricular hypertrophy, vessel muscularisation, combined with pulmonary pressures as markers to confirm PHT in animal models w x 10,19,21,23 . Indeed, Sakai et al. assessed the degree of pulmonary hypertension in coronary artery-ligated rats indirectly by measuring an increase in right ventricular w x systolic pressure 19 .
Various studies have reported an increased pulmonary artery sensitivity to 5-HT in models of PHT. For example, in a monocrotaline-induced model of PHT in rats, responses of isolated pulmonary arteries to 5-HT have been shown to be potentiated following the onset of PHT. In addition increased plasma levels of 5-HT in this particular model have led to the suggestion that 5-HT may be involved in the development and progression of PHT w x 10,11 . Similarly, we have recently demonstrated in large pulmonary arteries and pulmonary resistance arteries, that the response to 5-HT is increased in the chronic hypoxic, w x pulmonary hypertensive rat 13 . In humans and the fawn hooded rat, such hypersensitivity may be associated with w x abnormalities in platelet 5-HT storage 24,25 . Here, we have shown that there is an increased pulmonary pressor response to 5-HT in the ligated rabbits when compared to sham-operated controls. However, there is no evidence for abnormalities in platelet 5-HT storage in animal models or in humans with heart failure. In the chronic hypoxic rat model, the increase in vascular tone and decreased levels w x of cyclic GMP may contribute to the increased response i to 5-HT seen in pulmonary hypertensive states via inw x creased stimulation of an r5-HT -like receptor 13 . Thus, 1B a possible explanation for the pulmonary hyper-responsiveness of 5-HT seen in our studies could be an upregulation of a 5-HT receptor type or intracellular signalling pathway associated with the elevation in pulmonary vascular tone.
In pulmonary arteries and systemic arteries, 5-HT is known to cause endothelium-dependent and endotheliumindependent vasodilation via 5-HT -like and 5-HT -like 1D 7 w x receptors, respectively 26,27 . Hence the effect of i.v. 5-HT on systemic and pulmonary pressures will be determined by the balance between direct smooth muscle vasoconstriction and vasorelaxation. In these rabbits, we have ( )demonstrated that the direct contractile effect over-rides any vasodilator effect in the pulmonary circulation. However, the net effect of i.v. 5-HT was systemic vasodilation. Hence, the vasodilator effect of 5-HT over-rides the vasoconstrictor effect in the systemic circulation. This suggests that the distribution of andror contribution from 5-HT receptor subtypes is different in the systemic and pulmonary circulations. The increased response to 5-HT in the pulmonary circulation secondary to left ventricular dysfunction could, therefore, be due to increased vasoconstriction or decreased vasodilation via the 5-HT receptors. We propose that a decrease in production of endothelial-derived nitric oxide is unlikely as recent studies in isolated pulmonary resistance arteries from these animals indicate that endogenous nitric oxide synthase activity is enhanced w x in the coronary artery-ligated animals 28 . Immunocytochemical determination of endothelial nitric oxide synthase Ž also suggests an upregulation of this enzyme Docherty . and MacLean, unpublished . The possibility that vasodilation was decreased by a down regulation of endothelial or smooth muscle vasodilator 5-HT receptors cannot be excluded.
In contrast to the effects of 5-HT, we found that exogenous ET-1, which has been shown to be a potent vasoconstrictor of isolated human and rabbit pulmonary w x resistance vessels 28,29 had no effects on PAP. A number of possibilities for this lack of effect can be excluded. Following administration of the maximum ET-1 dose, a marked pulmonary arterial response could still be obtained with 5-HT demonstrating that the pulmonary circulation was still vasoactive. We also ruled out the possibility that ET-1 may exhibit a late response by demonstrating that a Ž bolus injection of the highest dose of ET-1 used 4 . nmolrkg , given following the usual range of concentrations, did not have any further effect on PAP after 30 min. ET-1 did, however, cause a profound increase in aortic pressure. Consistent with this selective pressor effect on the systemic circulation, we have recently shown that i.v. injection of ET-1 into patients with left ventricular dysfunction had little effect on their pulmonary pressure or resistance, whilst there was a marked increase in systemic w x pressure 30 .
The reason that i.v. ET-1 did not have any pulmonary pressor effects may be due to ET-1 being a strong stimulus for endothelium-derived nitric oxide release through the w x ET receptor 31 . As circulating ET-1 is in primary B1 contact with the endothelial lining of the pulmonary arteries, this vasodilator effect may override the direct effect of ET-1 on the pulmonary vascular smooth muscle. Whilst these results may suggest that plasma ET-1 is a marker, rather than a mediator of PHT, they do not exclude the possibility that locally, abluminally released ET-1 plays a role in increasing pulmonary vascular tone. ET-1 levels and ET-1 mRNA are increased in various tissues in heart failure models, but particularly in the endothelium of the w x pulmonary arteries and lungs 19 . ET-1 is thought to be more paracrine than endocrine in nature. As 75% of ET-1 w x is thought to be released abluminally 32 then plasma levels do not reflect the endothelin concentration to which the vascular smooth muscle is exposed, which must be considerably higher. Given that ET-1 spillover in the lungs w x is uniquely correlated with PVR 33 , this must relate to exposure of the pulmonary vascular smooth muscle to abluminally released ET-1. Indeed, endothelin receptor antagonists have been shown to inhibit the progression of PHT in coronary artery-ligated rats and chronic hypoxic rats which suggests that ET-1 is involved in this disease w x process 19,34 .
In conclusion, we have provided evidence that the coronary artery-ligated rabbit model of LVD develops changes often associated with pulmonary hypertension before changes in systemic arterial pressures are observed. Impaired left ventricular function is associated with an increase in PAP accompanied by the development of RVH and small pulmonary vessel muscularisation. The findings of a greater response to 5-HT in the coronary artery-ligated group confirm the observations of studies performed on isolated vessels from this model and strengthen the argument for 5-HT being involved in the development of PHT. The lack of effect of ET-1 when administered intravenously, despite being a potent vasoconstrictor in vitro, cannot exclude a role for this peptide when abluminally released. It is hoped that the development of this model will lead to an improved understanding of the mechanisms responsible for the development and progression of PHT secondary to heart failure.
